poisar

Stock

Lisata Therapeutics, Inc. LSTA

$1.77-15.11%

Overview

LSTA market data

Price History

LSTA price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.91
Diluted earnings per share over the trailing twelve months.
Beta
0.88
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.81 – $5.07
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $16 · P/B 1.10 · P/S 94.10.

Company news

10 captured
Lisata Therapeutics shares are trading lower after the company announced it has terminated its merger agreement with Kuva Labs.Benzinga · Jul 24, 2026, 5:54 PM
Lisata Therapeutics Terminates Merger Agreement With Kuva Labs; Termination Due To Kuva Labs' Failure To Obtain Financing, Accept Tendered Shares; Board To Carry Out Strategic Options Including Asset SaleBenzinga · Jul 24, 2026, 4:20 PM
8-K filing — LISATA THERAPEUTICS, INC. (LSTA)SEC EDGAR · Jul 24, 2026, 4:15 PM
Lisata Therapeutics Stock Falls After Hours: Here's WhyBenzinga · Jul 22, 2026, 5:03 AM
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.Benzinga · Jun 10, 2026, 12:15 PM
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving PremarketBenzinga · Jun 1, 2026, 10:01 AM
HC Wainwright & Co. Downgrades Lisata Therapeutics to NeutralBenzinga · May 15, 2026, 3:50 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: KalVista Pharmaceuticals, Inc. (Nasdaq – KALV), Thermon Group Holdings, Inc. (NYSE – THR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA)Globenewswire Inc · May 14, 2026, 6:15 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—TALK, LSTA, NSA, and KALVGlobenewswire Inc · May 12, 2026, 3:15 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Esperion Therapeutics, Inc. (Nasdaq – ESPR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA), SkyWater Technology, Inc. (Nasdaq - SKYT)Globenewswire Inc · May 5, 2026, 7:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock